The Food and Drug Administration is considering adding warning labels to antidepressants for people who are pregnant, despite ...

Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in ...

Experts on the panel shared many of the same views around SSRIs, arguing the risks of the drugs during pregnancy are greater ...

On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications ...

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...

Doctors on Monday urged the U.S. Food and Drug Administration to issue warnings to pregnant women against the use of certain ...

On July 21, the US Food and Drug Administration (FDA) convened a 10-expert panel to determine whether women should be warned about the potential dangers to their baby if they take antidepressants like ...

Members of an FDA expert panel discussed the risks and benefits of selective serotonin reuptake inhibitors, or SSRIs, for ...

Pregnancy presents a unique ethical dilemma. The unborn child cannot give consent, and damage sustained in the womb can ...

A Food and Drug Administration panel discussing the use of antidepressants during pregnancy Monday largely amounted to ...

An agency-sponsored forum included critics of psychiatry who believe the drugs can harm a developing fetus. Other experts said antidepressants were safe and necessary.

Drug makers are adding a notice to widely used antidepressants that babies of women who take the drugs late in pregnancy may experience jitteriness and other withdrawal symptoms, U.S. officials said.